Prevalence of Diabetes by Region

In 2013, the prevalence of treated diabetes was higher in the overseas departments, where it was up to twice as high as the national average. It was also higher in certain regions of mainland France, particularly in the North and Northeast, and in certain departments of the Île-de-France region, but it was lower in Brittany.

Click here for the detailed table of data on the prevalence of treated diabetes by department/region in 2012

Click here for the detailed table of diabetes prevalence data by gender, age group, and region in 2012

Click here for the detailed table of diabetes prevalence data by department/region in 2013

Click here for the detailed table of diabetes prevalence data by gender, age group, and region in 2013

Learn more:

• Mandereau-Bruno L, Denis P, Fagot-Campagna A, Fosse S. Prevalence of pharmacologically treated diabetes and regional disparities in France in 2012. Bull Epidémiol Hebd. 2014,30-31:493-99.

• A summary sheet, published in 2010, of the main data on the prevalence and incidence of diabetes available in France is available by clicking here.

• Ricci P, Blotière PO, Weill A, Simon D, Tuppin P, Ricordeau P, Allemand H. Treated diabetes: trends in France between 2000 and 2009. Bull Epidemiol Hebd 2010,42-43:425-31.

• Kusnik-Joinville O, Weill A, Ricordeau P, Allemand H. Treated diabetes in France in 2007: a prevalence rate close to 4% and growing geographic disparities. Bull Epidemiol Hebd 2008, 43: 409-413.

• Kusnik-Joinville O, Weill A, Salavane B, Ricordeau P, Allemand H. Treated diabetes: what changes occurred between 2000 and 2005? Pratiques et Organisation des Soins 2007, 38(1): 1-12

Incidence of diabetes-related complications by region

In 2013, in France, the incidence rates of hospitalizations for diabetes-related cardiovascular and podiatric complications varied significantly by region. Some regions, such as Limousin, had very high rates of people hospitalized for myocardial infarction (MI) compared to the national rate. Conversely, the overseas departments (with the exception of Guadeloupe) were characterized by lower rates of MI but higher rates of stroke. Hospitalization rates for lower limb amputation were very high in the overseas departments.

Click here to view the detailed table of incidence data for hospitalizations due to lower limb amputation by region in 2013

Click here to view the detailed table of incidence data for hospitalizations due to foot wounds by region in 2013

Click here for the detailed table of incidence data for hospitalizations due to myocardial infarction by region in 2013

Click here for the detailed table of incidence data on hospitalizations for stroke by region in 2013

Learn more:

• Fosse-Edorh S, Mandereau Bruno L, Hartemann-Heurtier A. The burden of hospitalizations for foot complications among people with diabetes receiving pharmacological treatment in France in 2013. Bull Epidemiol Hebd. 2015, (34-35):638-44.

• Fosse-Edorh S, Mandereau Bruno L, Olié V. The burden of hospitalizations for cardiovascular complications among people with diabetes receiving pharmacological treatment in France in 2013. Bull Epidemiol Hebd. 2015, (34-35):625-31.

Adherence to Recommended Screenings by Region

Follow-up on recommended screenings varied by region. French Guiana and Limousin stood out from other regions with relatively low follow-up rates compared to national averages. Conversely, Réunion recorded better follow-up for most indicators.

Learn more:

• Fosse-Edorh S, Mandereau Bruno L. Monitoring of recommended tests in diabetes surveillance in France in 2013. Bull Epidemiol Hebd. 2015, (34-35):645-54.

Diabetes in the Overseas Departments and Territories

The overseas departments (DOM) component of the 2007 Entred study examined the characteristics and health status of people with diabetes receiving treatment, as well as diabetes care in Guadeloupe and Martinique, French Guiana, and Réunion. The diabetic population in the overseas departments was younger than in mainland France (63 years vs. 65 years), predominantly female (65% women vs. 46%), and economically more disadvantaged than in mainland France. Type 2 diabetes was the most common form (96%). The vascular risk among people with type 2 diabetes was high, but obesity was less common than in mainland France. Diabetes was difficult to control, and insulin therapy was more common than in mainland France, although the average HbA1c level was higher there (7.4% vs. 7.1%). The profile of type 2 diabetes complications differed between the French overseas departments and mainland France; coronary complications and foot complications were less common there, whereas ophthalmological complications were more common. The quality of type 2 diabetes care was very similar to that in mainland France, and in some cases better.

Other specific studies have been conducted in the overseas departments and communities:

• Escal, conducted in 2003–2004 and analyzed by the Antilles-Guyana Interregional Epidemiology Unit (Cire) in Martinique,

• Maydia, conducted by the Indian Ocean Cire in Mayotte in 2008,

• Redia, on Réunion Island, conducted by the Center for Clinical Investigation and Clinical Epidemiology of Réunion with support from the French Institute for Public Health Surveillance (InVS).

Learn more:

• Lenclume V, Favier F. Rédia2 Cohort: Follow-up of participants in the REDIA survey on type 2 diabetes in Réunion. Results based on cross-sectional (2006–2009) and longitudinal (1999–2009) data. Center for Clinical Investigation and Clinical Epidemiology of Réunion, 2014. 240 p.

• Ndong JR, Romon I, Druet C, Prévot L, Hubert-Brierre R, Pascolini E, et al. Characteristics, vascular risk, complications, and quality of care for people with diabetes in the overseas departments and comparison with mainland France: Entred 2007–2010, France. Bull Epidemiol Hebd 2010,42-43:432-6.

• Fagot-Campagna A, Romon I, Fosse S, Roudier C. Prevalence and incidence of diabetes, and diabetes-related mortality, in France. Epidemiological summary. Saint-Maurice: Institute for Public Health Surveillance, November 2010. 12 p.

• Solet JL, Baroux N. Maydia 2008 Study – Study of the prevalence and characteristics of diabetes in the general population of Mayotte. Saint-Maurice: Institute for Health Surveillance, December 2009. 83 p.

• Solet JL, Pochet M, Baroux N, Benoit-Cattin T, De Montera AM, Sissoko D, Favier F, Fagot-Campagna A. Prevalence of type 2 diabetes and other cardiovascular risk factors in Mayotte. [Poster] In: Congress of the Francophone Diabetes Society, Lille, March 16–19, 2010. Diabetes Metab 2010, 36:A42.

• Ricci P, Blotière PO, Weill A, Simon D, Tuppin P, Ricordeau P, Allemand H. Treated diabetes: trends in France between 2000 and 2009. Bull Epidemiol Hebd 2010,42-43:425-31.

• Papoz L. Type 2 diabetes in the French overseas departments and territories: an unintended consequence of modernization. Bull Epidemiol Hebd 2002, 20-21: 89-90.

• Romon I, Jougla E, Catteau C, Para G, Cardoso T, Solet JL, Fagot-Campagna A. The significant burden of diabetes on mortality in the overseas departments. In: Alfédiam Congress, March 20–23, 2007, Marseille. Diabetes Metab 2007, 33: 1S75. [pdf - 66 KB]

• Romon I, Jougla E, Catteau C, Para G, Cardoso T, Solet JL, Fagot-Campagna A. High burden of diabetes on mortality in the French overseas departments. In: EDEG Congress, March 31–April 3, 2007, Cambridge, UK. [pdf - 74 KB]

• Cardoso T, Flamand C, Merle S, Quenel P, Fagot-Campagna A. Prevalence of diabetes in Martinique. Results of the Escal-Martinique survey, 2003–2004. In: Congress of the French-Speaking Association for the Study of Diabetes and Metabolic Diseases, March 7–10, 2006, Paris. Diabetes Metab 2006, 32: 1S62.

• Fagot-Campagna A, Fontbonne A. Expert assessment of surveillance for overweight-related diseases such as diabetes in French Polynesia. Mission report. Mission from February 4 to 15, 2007 [pdf - 993 KB]

• Favier F, Jaussent I, Moullec NL, Debussche X, Boyer MC, Schwager JC, Papoz L, REDIA Study Group. Prevalence of type 2 diabetes and central adiposity on Réunion Island: the REDIA study. Diabetes Res Clin Pract. 2005 Mar, 67(3):234-42.